Yahoo India Web Search

Sign In

Search results

  1. www.astellas.comAstellas Home page | Astellas Pharma Inc.

    5 days ago · Astellas is a company that aims to improve the health of people around the world with innovative and reliable products. Learn about its financial results, R&D strategy, sustainability, and partnering opportunities.

    • Investor Relations

      Thank you for visiting the Astellas Pharma Inc. Website. You...

    • Partnering

      Astellas' competitiveness comes from an extensive global...

    • Careers

      Developing innovative therapies is one of the most...

    • Suppliers

      Here our current and prospective suppliers can find...

    • Contact Us

      Contact Astellas Pharma Inc. Location: 2-5-1,...

    • WORLDWIDE

      WORLDWIDE - Astellas Home page | Astellas Pharma Inc.

    • Registration Form

      We have set Med-term Priorities, Initiatives, and Our...

    • About

      We have set Med-term Priorities, Initiatives, and Our...

  2. en.wikipedia.org › wiki › Astellas_PharmaAstellas Pharma - Wikipedia

    Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd ...

  3. www.astellas.com › inInnovation | Astellas Pharma India Pvt. Ltd.

    Learn how Astellas Pharma India leverages research and development and collaborations to create value for patients. Explore products, indications and dosages available in India.

  4. newsroom.astellas.us › 2023/05/12-Astellas-VEOZAHAstellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for ...

    May 12, 2023 · Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause. VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause. TOKYO, May 12, 2023 / PRNewswire / -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura ...

  5. www.biopharmadive.com › news › astellas-poseidaAstellas adds to ‘off-the-shelf’ cell therapy capabilities ...

    May 1, 2024 · Astellas Pharma announces a partnership with Poseida Therapeutics to develop two allogeneic cell therapies for solid tumors. The deal is part of Astellas' strategy to build up its genetic medicine capabilities and offset patent expirations.

    • Ben Fidler

  6. www.linkedin.com › company › astellaspharmaincAstellas Pharma | LinkedIn

    Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world. | At Astellas, we strive to be a cutting-edge, value-driven life science innovator.

  7. People also ask

  8. finance.yahoo.com › news › astellas-poseidaAstellas and Poseida Therapeutics Enter Into Research ...

    May 2, 2024 · Astellas Pharma and Poseida Therapeutics announce a research collaboration and license agreement to develop novel convertible CAR-T programs for solid tumors. The collaboration combines Poseida's allogeneic CAR-T platform with Astellas' ACCEL technology and MicAbodies.

  1. Searches related to Astellas Pharma

    astrazeneca